Post

The ligand screening was AI-assisted — DFT calculations narrowed candidates fast.

Electrospun nanofibers showed sustained release over 72 hours.

The freeze-drying cycle was optimized using a product temperature-aware approach.

Our target product profile guided formulation development from early stages.

The in vivo PK showed oral bioavailability of 64% in Sprague-Dawley rats.